Costo-efectividad de las intervenciones de enfermería para el manejo de úlceras por pie diabético: revisión sistemática
Las intervenciones de enfermería usadas para el tratamiento de las úlceras por pie diabético incluyen técnicas de cura tradicionales y avanzadas. Frecuentemente su elección depende del criterio personal de la enfermera, en lugar del reconocimiento de la relación costo-efectividad. El objetivo de est...
- Autores:
-
Vásquez Hernández, Skarlet Marcell
Rico Ardila, Dayana Lizeth
Gómez Camargo, Lesly Nathali
Álvarez Quintero, Lynda María
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2021
- Institución:
- Universidad Autónoma de Bucaramanga - UNAB
- Repositorio:
- Repositorio UNAB
- Idioma:
- spa
- OAI Identifier:
- oai:repository.unab.edu.co:20.500.12749/25701
- Palabra clave:
- Pie diabético
Manejo de atención al paciente
Úlcera del pie
Eficacia
Análisis costo-beneficio
Medical sciences
Life sciences
Diabetic foot
Patient care management
Leg ulcers
Efficacy
Cost-benefit analysis
Medical sciences
Life sciences
Health sciences
Pé diabético
Manejo do cuidado ao paciente
Úlcera do pé
Eficácia
Análise de custo-benefício
Ciências médicas
Ciências da vida
Ciências da saúde
Ciencias médicas
Ciencias de la vida
Ciencias de la salud
- Rights
- License
- http://creativecommons.org/licenses/by-nc-nd/2.5/co/
| id |
UNAB2_738b6c62d6ac4193f20083e3302fdc3c |
|---|---|
| oai_identifier_str |
oai:repository.unab.edu.co:20.500.12749/25701 |
| network_acronym_str |
UNAB2 |
| network_name_str |
Repositorio UNAB |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Costo-efectividad de las intervenciones de enfermería para el manejo de úlceras por pie diabético: revisión sistemática |
| dc.title.translated.eng.fl_str_mv |
Cost-effectiveness of nursing interventions for diabetic foot ulcer management: systematic review |
| dc.title.translated.por.fl_str_mv |
Custo-efetividade das intervenções de enfermagem para o tratamento das úlceras do pé diabético: uma revisão sistemática |
| title |
Costo-efectividad de las intervenciones de enfermería para el manejo de úlceras por pie diabético: revisión sistemática |
| spellingShingle |
Costo-efectividad de las intervenciones de enfermería para el manejo de úlceras por pie diabético: revisión sistemática Pie diabético Manejo de atención al paciente Úlcera del pie Eficacia Análisis costo-beneficio Medical sciences Life sciences Diabetic foot Patient care management Leg ulcers Efficacy Cost-benefit analysis Medical sciences Life sciences Health sciences Pé diabético Manejo do cuidado ao paciente Úlcera do pé Eficácia Análise de custo-benefício Ciências médicas Ciências da vida Ciências da saúde Ciencias médicas Ciencias de la vida Ciencias de la salud |
| title_short |
Costo-efectividad de las intervenciones de enfermería para el manejo de úlceras por pie diabético: revisión sistemática |
| title_full |
Costo-efectividad de las intervenciones de enfermería para el manejo de úlceras por pie diabético: revisión sistemática |
| title_fullStr |
Costo-efectividad de las intervenciones de enfermería para el manejo de úlceras por pie diabético: revisión sistemática |
| title_full_unstemmed |
Costo-efectividad de las intervenciones de enfermería para el manejo de úlceras por pie diabético: revisión sistemática |
| title_sort |
Costo-efectividad de las intervenciones de enfermería para el manejo de úlceras por pie diabético: revisión sistemática |
| dc.creator.fl_str_mv |
Vásquez Hernández, Skarlet Marcell Rico Ardila, Dayana Lizeth Gómez Camargo, Lesly Nathali Álvarez Quintero, Lynda María |
| dc.contributor.author.none.fl_str_mv |
Vásquez Hernández, Skarlet Marcell Rico Ardila, Dayana Lizeth Gómez Camargo, Lesly Nathali Álvarez Quintero, Lynda María |
| dc.subject.spa.fl_str_mv |
Pie diabético Manejo de atención al paciente Úlcera del pie Eficacia Análisis costo-beneficio |
| topic |
Pie diabético Manejo de atención al paciente Úlcera del pie Eficacia Análisis costo-beneficio Medical sciences Life sciences Diabetic foot Patient care management Leg ulcers Efficacy Cost-benefit analysis Medical sciences Life sciences Health sciences Pé diabético Manejo do cuidado ao paciente Úlcera do pé Eficácia Análise de custo-benefício Ciências médicas Ciências da vida Ciências da saúde Ciencias médicas Ciencias de la vida Ciencias de la salud |
| dc.subject.keywords.eng.fl_str_mv |
Medical sciences Life sciences Diabetic foot Patient care management Leg ulcers Efficacy Cost-benefit analysis Medical sciences Life sciences Health sciences |
| dc.subject.keywords.por.fl_str_mv |
Pé diabético Manejo do cuidado ao paciente Úlcera do pé Eficácia Análise de custo-benefício Ciências médicas Ciências da vida Ciências da saúde |
| dc.subject.lemb.spa.fl_str_mv |
Ciencias médicas Ciencias de la vida |
| dc.subject.proposal.spa.fl_str_mv |
Ciencias de la salud |
| description |
Las intervenciones de enfermería usadas para el tratamiento de las úlceras por pie diabético incluyen técnicas de cura tradicionales y avanzadas. Frecuentemente su elección depende del criterio personal de la enfermera, en lugar del reconocimiento de la relación costo-efectividad. El objetivo de este estudio es identificar las intervenciones de enfermería de mayor costo-efectividad para el manejo de pacientes con úlceras por pie diabético. Metodología. Se realizó una revisión sistemática en Pubmed, Cochrane y la Biblioteca Virtual De La Salud. Se incluyeron estudios aleatorizados y no aleatorizados de cualquier intervención de enfermería usada para el manejo de úlcera por pie diabético con reporte de costo-efectividad. La selección de los artículos elegibles fue realizada por dos evaluadores independientes. El riesgo de sesgos fue evaluado con las guías Critical Appraisal Skills Programme. Resultados. Seis de los ocho artículos incluidos fueron clasificados con alto riesgo de sesgos. Las dos intervenciones en las que se evidenció una mejor relación costo-efectividad en comparación con el grupo control fueron el uso de Beta-Glucan gel (comparado con placebo) y la terapia de presión negativa (comparada con terapia de herida húmeda avanzada). Discusión. Guías nacionales e internacionales para el manejo de enfermería de úlceras por pie diabético proponen al menos 15 diferentes intervenciones. Sin embargo, la escasa disponibilidad de estudios de alta calidad sobre la relación costo-efectividad dificulta la selección y genera mayor variabilidad en las prácticas de enfermería. Conclusión. Es necesario realizar estudios de la relación costo-efectividad con comparaciones directas de las intervenciones de enfermería para el manejo de úlceras por pie diabético. |
| publishDate |
2021 |
| dc.date.issued.none.fl_str_mv |
2021-02-09 |
| dc.date.accessioned.none.fl_str_mv |
2024-07-24T15:16:26Z |
| dc.date.available.none.fl_str_mv |
2024-07-24T15:16:26Z |
| dc.type.eng.fl_str_mv |
Article |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
| dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.local.spa.fl_str_mv |
Artículo |
| dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.redcol.none.fl_str_mv |
http://purl.org/redcol/resource_type/ART |
| format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.identifier.issn.spa.fl_str_mv |
i-ISSN 0123-7047 e-ISSN 2382-4603 |
| dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/20.500.12749/25701 |
| dc.identifier.instname.spa.fl_str_mv |
instname:Universidad Autónoma de Bucaramanga UNAB |
| dc.identifier.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional UNAB |
| dc.identifier.repourl.spa.fl_str_mv |
repourl:https://repository.unab.edu.co |
| dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.29375/01237047.3832 |
| identifier_str_mv |
i-ISSN 0123-7047 e-ISSN 2382-4603 instname:Universidad Autónoma de Bucaramanga UNAB reponame:Repositorio Institucional UNAB repourl:https://repository.unab.edu.co |
| url |
http://hdl.handle.net/20.500.12749/25701 https://doi.org/10.29375/01237047.3832 |
| dc.language.iso.spa.fl_str_mv |
spa |
| language |
spa |
| dc.relation.spa.fl_str_mv |
https://revistas.unab.edu.co/index.php/medunab/article/view/3832/3391 |
| dc.relation.uri.spa.fl_str_mv |
https://revistas.unab.edu.co/index.php/medunab/issue/view/271 |
| dc.relation.references.none.fl_str_mv |
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1211-1259. doi: http://doi.org/10.1016/ S0140-6736(17)32154-2 GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018. doi: https://doi. org/10.1016/S0140-6736(18)32203-7 Institute for Health Metrics and Evaluation. Global Health Data Exchange [Internet]. GBD results tool; 2020 [citado 10 de septiembre de 2020]. Recuperado a partir de: http://ghdx.healthdata.org/gbd-resultstool Vargas-Uricoechea H and Casas-Figueroa LÁ. An Epidemiologic Analysis of Diabetes in Colombia. Annals of Global Health. 2016; 81(6), pp.742-753. doi: https://doi.org/10.1016/j.aogh.2015.11.001 Emerging Risk Factors Collaboration, Sarwar N, GaoP, Seshasai SR, Gobin R, Kaptoge S, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative metaanalysis of 102 prospective studies. Lancet. 2010; 375(9733):2215-22. doi: https://doi.org/10.1016/ S0140-6736(10)60484-9 Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet. 2014; 383(9933):1973-80. doi: https://doi. org/10.1016/S0140-6736(14)60040-4 Seferovic JP, Bentley-Lewis R, Claggett B, Diaz R, Gerstein HC, Køber LV, et al. Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration. J Diabetes Res. 2018. 1631263. doi: https://doi.org/10.1155/2018/1631263 Saed L, Deihim Z, Naghshbandi MK, Rajabnia M, Naleini SN. Cardiovascular events in patients with over 10 years history of type 2 diabetes mellitus. Diabetes Metab Syndr. 2019; 13(1):68-72. doi: https://doi.org/10.1016/j.dsx.2018.08.026 Kastarinen M., Juutilainen A., Kastarinen H., Salomaa V., Karhapaa P., Tuomilehto J., et al. Risk factors for end-stage renal disease in a community based population: 26-year follow-up of 25,821 men and women in eastern Finland. J. Intern. Med. 2010; 267(6): 612-620. doi: https://doi.org/10.1111/j.1365- 2796.2009.02197.x 10. Shen Y, Cai R, Sun J, Dong X, Huang R, Tian S, Wang S. Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis. Endocrine. 2017; 55(1):66-76. doi: https://doi.org/10.1007/s12020-016-1014-6 Vrsalovic M, Vucur K, Vrsalovic Presecki A, Fabijanic D, Milosevic M. Impact of diabetes on mortality in peripheral artery disease: a metaanalysis. Clin Cardiol. 2017; 40(5):287-291. doi: https://doi.org/10.1002/clc.22657 Blanes JI., Lluch I., Morillas C., Nogueira JM., Hernández A. Capítulo 3 Etiopatogenia del pie diabético. En: J. Marinel.lo Roura, Coordinador. Tratado del pie diabético. España: Jarpyo Editores; 2002. p33- 41. University of Salford Manchester. Limbless statistics. United Kingdom. 2005. Citado 3 nov 2018. Recuperado a partir de: http://www.limblessstatistics. org/ Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehab 2008;89(3):422-429. https://doi.org/10.1016/j.apmr.2007.11.005 Font-Jiménez I, Llaurado-Serra M, Roig-Garcia M, De Los Mozos-Perez B, Acebedo-Urdiales S. Retrospective study of the evolution of the incidence of non-traumatic lower-extremity amputations (2007-2013) and risk factors of reamputation. Prim Care Diabetes. 2016;10(6):434-441. doi: https://doi. org/10.1016/j.pcd.2016.04.001 Vaidya V, Gangan N, Sheehan J. Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15(3):487- 497. doi: https://doi.org/10.1586/14737167.2015.10 24661 Kerr M, Barron E, Chadwick P, et al. The cost of diabetic foot ulcers and amputations to the National Health Service in England. Diabet Med. 2019;36(8):995-1002. doi: https://doi.org/10.1111/ dme.13973 International Diabetes Federation. Atlas de la Diabetes. Séptima Edición. 2015. Citado 3 nov 2018. Recuperado a partir de: https://www. fundaciondiabetes.org/upload/publicaciones_ ficheros/95/IDF_Atlas_2015_SP_WEB_oct2016. pdf Organización Mundial de la Salud. Informe mundial sobre la diabetes. 2016. Citado 3 nov 2018. Recuperado a partir de: https://www.who.int/ diabetes/global-report/es/ Barcelo A, Arredondo A, Gordillo-Tobar A, Segovia J, Qiang A. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers. J Glob Health. 2017;7(2):020410. doi: https://doi.org/10.7189/jogh.07.020410 Hicks CW, Selvarajah S, Mathioudakis N, et al. Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers. J Vasc Surg. 2014;60(5):1247-1254.e2. doi: https://doi. org/10.1016/j.jvs.2014.05.009 González J, Walker J, Einarson T. Cost-of-illness study of type 2 diabetes mellitus in Colombia. Rev Panam Salud Publica. 2009;26(1):55-63. Recuperado a partir de: https://www.scielosp.org/ article/rpsp/2009.v26n1/55-63/ doi: https://doi. org/10.1590/S1020-49892009000700009 Méndez FA, Rivero WM. Costos médicos directos de complicación en el tratamiento en pacientes con diabetes mellitus en Colombia 2016 [tesis en Internet]. [Bogotá]: Universidad de Ciencias aplicadas y ambientales; 2016. [Citado 3 nov 2018. Recuperado a partir de: https://repository.udca.edu. co/bitstream/11158/859/1/TESIS%20PARA%20 IMPRESION%20FINAL.pdf Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for medicare and private insurers [published correction appears in Diabetes Care. 2014 Sep;37(9):2660]. Diabetes Care. 2014;37(3):651- 658. doi: https://doi.org/10.2337/dc13-2176 Torra J. Economía de la Salud del Pie Diabético: Una revisión integrativa. En: 2ª Cumbre de las Americas del Pie Diabético; 2017 Oct 12. Ciudad de México. Citado 10 sep 2020. Recuperado a partir de: https:// www.researchgate.net/publication/321151845_ Economia_de_la_Salud_del_Pie_Diabetico_Una_ revision_integrativa-_Diabetic_Foot_Health_ Economics_An_integrative_review_Presentation_ in_Spanish Wang C, Guo M, Zhang N, Wang G. Effectiveness of honey dressing in the treatment of diabetic foot ulcers: A systematic review and meta-analysis. Complement Ther Clin Pract. 2019;34:123-131. doi: https://doi.org/10.1016/j.ctcp.2018.09.004 Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Ann N Y Acad Sci. 2018;1411(1):153-165. doi: https://doi.org/10.1111/ nyas.13569 Martí-Carvajal AJ, Gluud C, Nicola S, Simancas- Racines D, Reveiz L, Oliva P, Cedeño-Taborda J. Growth factors for treating diabetic foot ulcers. Cochrane Database Syst Rev. 2015;(10):CD008548. doi: https://doi.org/10.1002/14651858.CD008548. pub2 Saco M, Howe N, Nathoo R, Cherpelis B. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success. Dermatol Online J. 2016;22(8). pii: 13030/qt7ph5v17z. Recuperado a partir de: https://www.researchgate.net/ publication/307566354_Comparing_the_efficacies_ of_alginate_foam_hydrocolloid_hydrofiber_and_ hydrogel_dressings_in_the_management_of_ diabetic_foot_ulcers_and_venous_leg_ulcers_A_ systematic_review_and_meta-analysis_examining O’Meara S, Cullum N, Majid M, Sheldon T. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration. Health Technol Assess. 2000; 4(21):1-237. Recuperado a partir de: https://www. journalslibrary.nihr.ac.uk/hta/hta4210#/abstract doi: https://doi.org/10.3310/hta4210 Snyder RJ, Hanft JR. Diabetic foot ulcers--effects on QOL, costs, and mortality and the role of standard wound care and advanced-care therapies. Ostomy Wound Manage. 2009 Nov 1;55(11):28-38. Recuperado a partir de: https://www.semanticscholar. org/paper/Diabetic-Foot-Ulcers%3A-The- Importance-of-Patient-and-Jagadish-McNally/69658 d1af9aa37c72b38cc661ad7bc2c2d9d6b50 Cutting KF. The cost-effectiveness of a novel soluble beta-glucan gel. J Wound Care. 2017;26(5):228-234. doi: https://doi.org/10.12968/jowc.2017.26.5.228 Driver VR, Blume PA. Evaluation of wound care and health-care use costs in patients with diabetic foot ulcers treated with negative pressure wound therapy versus advanced moist wound therapy. J Am Podiatr Med Assoc. 2014; 104(2):147-53. doi: https://doi. org/10.7547/0003-0538-104.2.147 Waycaster CR, Gilligan AM, Motley TA. Cost- Effectiveness of Becaplermin Gel on Diabetic Foot Ulcer Healing. J Am Podiatr Med Assoc. 2016;106(4):273-82. doi: https://doi.org/10.7547/15- 004 Zelen CM, Orgill DP, Serena T, Galiano R, Carter MJ, DiDomenico LA, et al. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safetyand cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers. Int Wound J. 2017;14(2):307-315. doi: https://doi.org/10.1111/ iwj.12600 Gilligan AM, Waycaster CR, Landsman AL. Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products. J Wound Care. 2015;24(3):149-56. doi: https://doi. org/10.12968/jowc.2015.24.3.149 Gilligan AM, Waycaster CR, Motley TA. Costeffectiveness of becaplermin gel on wound healing of diabetic foot ulcers. Wound Repair Regen. 2015;23(3):353-60. doi: https://doi.org/10.1111/ wrr.12285 Rice JB, Desai U, Ristovska L, Cummings AK, Birnbaum HG, Skornicki M, et al. Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers. J Med Econ. 2015; 18(8):586-95. doi: https://doi.org/10.3111/13696998.2015.1031793 Wilasrusmee C, Marjareonrungrung M, Eamkong S, Attia J, Poprom N, Jirasisrithum S, et al. Maggot therapy for chronic ulcer: a retrospective cohort and a meta-analysis. Asian J Surg. 2014;37(3):138-47. doi: https://doi.org/10.1016/j.asjsur.2013.09.005 Aalaa M, Malazy OT, Sanjari M, Peimani M, Mohajeri-Tehrani M. Nurses’ role in diabetic foot prevention and care; a review. J Diabetes Metab Disord. 2012;11(1):24. Published 2012 Nov 21. doi: https://doi.org/10.1186/2251-6581-11-24 Registered Nurses’ Association of Ontario. Valoración y manejo de las úlceras de pie diabético. En: Grispun D, Director. Guías de buenas prácticas clínicas. Canadá; 2013. p1- 162. Recuperado a partir de: https://rnao.ca/ sites/rnao-ca/files/2015_-_BPG_Foot_16_01_2015_- _2nd_Edition.pdf COLPEDIS. Grupo Colombiano de Pie Diabético. Guías Colombianas para la prevención, diagnóstico y tratamiento del pie diabético. Tercera edición. 2019; 1- 63. Recuperado a partir de: https://es.scribd.com/ document/411231925/Guias-Colombianas-Para- La-Prevencion-Diagnostico-y-Tratamiento-Del-Pie- Diabetico-Un-Manejo-Integral-2019 Parker CN, Van Netten JJ, Parker TJ, et al. Differences between national and international guidelines for the management of diabetic foot disease. Diabetes Metab Res Rev. 2019;35(2):e3101. doi: https://doi. org/10.1002/dmrr.3101 Beuscher T. Guidelines for Diabetic Foot Care. A Template for the Care of All Feet. J Wound Ostomy Continence Nurs. 2019;46(3):241-245. Recuperado a partir de: https://nursing.201905000-00014. Schaper NC, van Netten JJ, Apelqvist J, et al. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36 Suppl 1:e3266. doi: https:// doi.org/10.1002/dmrr.3266 Asociación latinoamericana de diabetes. Guías ALAD sobre el Diagnóstico, Control y Tratamiento de la Diabetes Mellitus Tipo 2 con Medicina Basada en Evidencia Edición 2019. 2019. Revista de la ALAD. Recuperado a partir de: http://www.revistaalad.com/ guias/5600AX191_guias_alad_2019.pdf |
| dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ |
| dc.rights.local.spa.fl_str_mv |
Abierto (Texto Completo) |
| dc.rights.creativecommons.*.fl_str_mv |
Atribución-NoComercial-SinDerivadas 2.5 Colombia |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ Abierto (Texto Completo) Atribución-NoComercial-SinDerivadas 2.5 Colombia http://purl.org/coar/access_right/c_abf2 |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.grantor.spa.fl_str_mv |
Universidad Autónoma de Bucaramanga UNAB |
| dc.publisher.faculty.spa.fl_str_mv |
Facultad Ciencias de la Salud |
| dc.source.spa.fl_str_mv |
Vol. 24 Núm. 1 (2021): abril - julio, 2021: Pie Diabético, Trastornos Relacionados con Sustancias, Educación Médica; 13-26 |
| institution |
Universidad Autónoma de Bucaramanga - UNAB |
| bitstream.url.fl_str_mv |
https://repository.unab.edu.co/bitstream/20.500.12749/25701/2/license.txt https://repository.unab.edu.co/bitstream/20.500.12749/25701/3/Art%c3%adculo.pdf.jpg https://repository.unab.edu.co/bitstream/20.500.12749/25701/1/Art%c3%adculo.pdf |
| bitstream.checksum.fl_str_mv |
737346e09d47a3db691f1370de49426a 8f4b2079e9cf1d15004e3f23986524f8 5733801e062300f2b7098ae9f4497821 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional | Universidad Autónoma de Bucaramanga - UNAB |
| repository.mail.fl_str_mv |
repositorio@unab.edu.co |
| _version_ |
1814278402994077696 |
| spelling |
Vásquez Hernández, Skarlet Marcell1261f568-9283-47b5-9897-3a354ea0210aRico Ardila, Dayana Lizeth9f1a748d-004a-4195-ba50-3bb67e949a88Gómez Camargo, Lesly Nathali9fdc1712-818b-435a-ac8e-88ec091b72b3Álvarez Quintero, Lynda María56d84d23-98a8-4c61-bd0b-8615e1e920022024-07-24T15:16:26Z2024-07-24T15:16:26Z2021-02-09i-ISSN 0123-7047e-ISSN 2382-4603http://hdl.handle.net/20.500.12749/25701instname:Universidad Autónoma de Bucaramanga UNABreponame:Repositorio Institucional UNABrepourl:https://repository.unab.edu.cohttps://doi.org/10.29375/01237047.3832Las intervenciones de enfermería usadas para el tratamiento de las úlceras por pie diabético incluyen técnicas de cura tradicionales y avanzadas. Frecuentemente su elección depende del criterio personal de la enfermera, en lugar del reconocimiento de la relación costo-efectividad. El objetivo de este estudio es identificar las intervenciones de enfermería de mayor costo-efectividad para el manejo de pacientes con úlceras por pie diabético. Metodología. Se realizó una revisión sistemática en Pubmed, Cochrane y la Biblioteca Virtual De La Salud. Se incluyeron estudios aleatorizados y no aleatorizados de cualquier intervención de enfermería usada para el manejo de úlcera por pie diabético con reporte de costo-efectividad. La selección de los artículos elegibles fue realizada por dos evaluadores independientes. El riesgo de sesgos fue evaluado con las guías Critical Appraisal Skills Programme. Resultados. Seis de los ocho artículos incluidos fueron clasificados con alto riesgo de sesgos. Las dos intervenciones en las que se evidenció una mejor relación costo-efectividad en comparación con el grupo control fueron el uso de Beta-Glucan gel (comparado con placebo) y la terapia de presión negativa (comparada con terapia de herida húmeda avanzada). Discusión. Guías nacionales e internacionales para el manejo de enfermería de úlceras por pie diabético proponen al menos 15 diferentes intervenciones. Sin embargo, la escasa disponibilidad de estudios de alta calidad sobre la relación costo-efectividad dificulta la selección y genera mayor variabilidad en las prácticas de enfermería. Conclusión. Es necesario realizar estudios de la relación costo-efectividad con comparaciones directas de las intervenciones de enfermería para el manejo de úlceras por pie diabético.Nursing interventions used for the treatment of diabetic foot ulcers include traditional and advanced healing techniques. Often their choice depends on the nurse’s personal judgment, rather than recognition of cost-effectiveness. The objective of this study is to identify the most cost-effective nursing interventions for the management of patients with diabetic foot ulcers. Methodology. A systematic review was conducted at Pubmed, Cochrane and the Virtual Health Library. Randomized and non-randomized studies of any nursing intervention used for diabetic foot ulcer management with reported cost-effectiveness were included. The selection of eligible articles was made by two independent reviewers. The risk of bias was assessed using the following guidelines: Critical Appraisal Skills Programme. Results. Six of the eight included articles were classified at high risk of bias. The two interventions in which a better cost-effectiveness ratio was evidenced compared to the control group were the use of Beta-Glucan gel (compared to placebo) and negative pressure wound therapy (compared to advanced wet wound therapy). Discussion. National and international guidelines for the nursing management of diabetic foot ulcers propose at least 15 different interventions. However, the limited availability of high-quality cost-effectiveness studies makes selection difficult and generates greater variability in nursing practices. Conclusion. Cost-effectiveness studies with direct comparisons of nursing interventions for diabetic foot ulcer management are needed.As intervenções de enfermagem usadas para tratar úlceras do pé diabético incluem técnicas de cura tradicionais e avançadas. Frequentemente, sua escolha depende do julgamento pessoal da enfermeira, ao invés do reconhecimento da relação custo-efetividade. O objetivo deste estudo é identificar as intervenções de enfermagem com um maior custo-efetividade para o tratamento de pacientes com úlceras de pé diabético. Metodologia. Foi realizada uma revisão sistemática no Pubmed, Cochrane e na Biblioteca Virtual em Saúde. Foram incluídos estudos randomizados e não randomizados de qualquer intervenção de enfermagem utilizada para o tratamento de úlceras do pé diabético com relatórios de custo-efetividade. A seleção dos artigos elegíveis foi feita por dois avaliadores independentes. O risco de tendências foi avaliado com as diretrizes do Critical Appraisal Skills Program. Resultados. Seis dos oito artigos incluídos foram classificados como de alto risco de tendência. As duas intervenções que mostraram uma melhor relação custo-efetividade em comparação com o grupo de controle foram o uso de gel de Beta-Glucan (em comparação com o placebo) e a terapia de pressão negativa (em comparação com a terapia avançada de feridas úmidas). Discussão. Diretrizes nacionais e internacionais para o tratamento de enfermagem de úlceras do pé diabético propõem pelo menos 15 intervenções diferentes. No entanto, a disponibilidade limitada de estudos de alta qualidade sobre a relação custo-efetividade torna difícil a seleção e leva a uma maior variabilidade nas práticas de enfermagem. Conclusão. São necessários estudos que tratem a relação custo-efetividade com comparações diretas de intervenções de enfermagem para o tratamento de úlceras do pé diabético.application/pdfspahttps://revistas.unab.edu.co/index.php/medunab/article/view/3832/3391https://revistas.unab.edu.co/index.php/medunab/issue/view/271GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1211-1259. doi: http://doi.org/10.1016/ S0140-6736(17)32154-2GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018. doi: https://doi. org/10.1016/S0140-6736(18)32203-7Institute for Health Metrics and Evaluation. Global Health Data Exchange [Internet]. GBD results tool; 2020 [citado 10 de septiembre de 2020]. Recuperado a partir de: http://ghdx.healthdata.org/gbd-resultstoolVargas-Uricoechea H and Casas-Figueroa LÁ. An Epidemiologic Analysis of Diabetes in Colombia. Annals of Global Health. 2016; 81(6), pp.742-753. doi: https://doi.org/10.1016/j.aogh.2015.11.001Emerging Risk Factors Collaboration, Sarwar N, GaoP, Seshasai SR, Gobin R, Kaptoge S, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative metaanalysis of 102 prospective studies. Lancet. 2010; 375(9733):2215-22. doi: https://doi.org/10.1016/ S0140-6736(10)60484-9Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet. 2014; 383(9933):1973-80. doi: https://doi. org/10.1016/S0140-6736(14)60040-4Seferovic JP, Bentley-Lewis R, Claggett B, Diaz R, Gerstein HC, Køber LV, et al. Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration. J Diabetes Res. 2018. 1631263. doi: https://doi.org/10.1155/2018/1631263Saed L, Deihim Z, Naghshbandi MK, Rajabnia M, Naleini SN. Cardiovascular events in patients with over 10 years history of type 2 diabetes mellitus. Diabetes Metab Syndr. 2019; 13(1):68-72. doi: https://doi.org/10.1016/j.dsx.2018.08.026Kastarinen M., Juutilainen A., Kastarinen H., Salomaa V., Karhapaa P., Tuomilehto J., et al. Risk factors for end-stage renal disease in a community based population: 26-year follow-up of 25,821 men and women in eastern Finland. J. Intern. Med. 2010; 267(6): 612-620. doi: https://doi.org/10.1111/j.1365- 2796.2009.02197.x10. Shen Y, Cai R, Sun J, Dong X, Huang R, Tian S, Wang S. Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis. Endocrine. 2017; 55(1):66-76. doi: https://doi.org/10.1007/s12020-016-1014-6Vrsalovic M, Vucur K, Vrsalovic Presecki A, Fabijanic D, Milosevic M. Impact of diabetes on mortality in peripheral artery disease: a metaanalysis. Clin Cardiol. 2017; 40(5):287-291. doi: https://doi.org/10.1002/clc.22657Blanes JI., Lluch I., Morillas C., Nogueira JM., Hernández A. Capítulo 3 Etiopatogenia del pie diabético. En: J. Marinel.lo Roura, Coordinador. Tratado del pie diabético. España: Jarpyo Editores; 2002. p33- 41.University of Salford Manchester. Limbless statistics. United Kingdom. 2005. Citado 3 nov 2018. Recuperado a partir de: http://www.limblessstatistics. org/Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehab 2008;89(3):422-429. https://doi.org/10.1016/j.apmr.2007.11.005Font-Jiménez I, Llaurado-Serra M, Roig-Garcia M, De Los Mozos-Perez B, Acebedo-Urdiales S. Retrospective study of the evolution of the incidence of non-traumatic lower-extremity amputations (2007-2013) and risk factors of reamputation. Prim Care Diabetes. 2016;10(6):434-441. doi: https://doi. org/10.1016/j.pcd.2016.04.001Vaidya V, Gangan N, Sheehan J. Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15(3):487- 497. doi: https://doi.org/10.1586/14737167.2015.10 24661Kerr M, Barron E, Chadwick P, et al. The cost of diabetic foot ulcers and amputations to the National Health Service in England. Diabet Med. 2019;36(8):995-1002. doi: https://doi.org/10.1111/ dme.13973International Diabetes Federation. Atlas de la Diabetes. Séptima Edición. 2015. Citado 3 nov 2018. Recuperado a partir de: https://www. fundaciondiabetes.org/upload/publicaciones_ ficheros/95/IDF_Atlas_2015_SP_WEB_oct2016. pdfOrganización Mundial de la Salud. Informe mundial sobre la diabetes. 2016. Citado 3 nov 2018. Recuperado a partir de: https://www.who.int/ diabetes/global-report/es/Barcelo A, Arredondo A, Gordillo-Tobar A, Segovia J, Qiang A. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers. J Glob Health. 2017;7(2):020410. doi: https://doi.org/10.7189/jogh.07.020410Hicks CW, Selvarajah S, Mathioudakis N, et al. Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers. J Vasc Surg. 2014;60(5):1247-1254.e2. doi: https://doi. org/10.1016/j.jvs.2014.05.009González J, Walker J, Einarson T. Cost-of-illness study of type 2 diabetes mellitus in Colombia. Rev Panam Salud Publica. 2009;26(1):55-63. Recuperado a partir de: https://www.scielosp.org/ article/rpsp/2009.v26n1/55-63/ doi: https://doi. org/10.1590/S1020-49892009000700009Méndez FA, Rivero WM. Costos médicos directos de complicación en el tratamiento en pacientes con diabetes mellitus en Colombia 2016 [tesis en Internet]. [Bogotá]: Universidad de Ciencias aplicadas y ambientales; 2016. [Citado 3 nov 2018. Recuperado a partir de: https://repository.udca.edu. co/bitstream/11158/859/1/TESIS%20PARA%20 IMPRESION%20FINAL.pdfRice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for medicare and private insurers [published correction appears in Diabetes Care. 2014 Sep;37(9):2660]. Diabetes Care. 2014;37(3):651- 658. doi: https://doi.org/10.2337/dc13-2176Torra J. Economía de la Salud del Pie Diabético: Una revisión integrativa. En: 2ª Cumbre de las Americas del Pie Diabético; 2017 Oct 12. Ciudad de México. Citado 10 sep 2020. Recuperado a partir de: https:// www.researchgate.net/publication/321151845_ Economia_de_la_Salud_del_Pie_Diabetico_Una_ revision_integrativa-_Diabetic_Foot_Health_ Economics_An_integrative_review_Presentation_ in_SpanishWang C, Guo M, Zhang N, Wang G. Effectiveness of honey dressing in the treatment of diabetic foot ulcers: A systematic review and meta-analysis. Complement Ther Clin Pract. 2019;34:123-131. doi: https://doi.org/10.1016/j.ctcp.2018.09.004Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Ann N Y Acad Sci. 2018;1411(1):153-165. doi: https://doi.org/10.1111/ nyas.13569Martí-Carvajal AJ, Gluud C, Nicola S, Simancas- Racines D, Reveiz L, Oliva P, Cedeño-Taborda J. Growth factors for treating diabetic foot ulcers. Cochrane Database Syst Rev. 2015;(10):CD008548. doi: https://doi.org/10.1002/14651858.CD008548. pub2Saco M, Howe N, Nathoo R, Cherpelis B. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success. Dermatol Online J. 2016;22(8). pii: 13030/qt7ph5v17z. Recuperado a partir de: https://www.researchgate.net/ publication/307566354_Comparing_the_efficacies_ of_alginate_foam_hydrocolloid_hydrofiber_and_ hydrogel_dressings_in_the_management_of_ diabetic_foot_ulcers_and_venous_leg_ulcers_A_ systematic_review_and_meta-analysis_examiningO’Meara S, Cullum N, Majid M, Sheldon T. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration. Health Technol Assess. 2000; 4(21):1-237. Recuperado a partir de: https://www. journalslibrary.nihr.ac.uk/hta/hta4210#/abstract doi: https://doi.org/10.3310/hta4210Snyder RJ, Hanft JR. Diabetic foot ulcers--effects on QOL, costs, and mortality and the role of standard wound care and advanced-care therapies. Ostomy Wound Manage. 2009 Nov 1;55(11):28-38. Recuperado a partir de: https://www.semanticscholar. org/paper/Diabetic-Foot-Ulcers%3A-The- Importance-of-Patient-and-Jagadish-McNally/69658 d1af9aa37c72b38cc661ad7bc2c2d9d6b50Cutting KF. The cost-effectiveness of a novel soluble beta-glucan gel. J Wound Care. 2017;26(5):228-234. doi: https://doi.org/10.12968/jowc.2017.26.5.228Driver VR, Blume PA. Evaluation of wound care and health-care use costs in patients with diabetic foot ulcers treated with negative pressure wound therapy versus advanced moist wound therapy. J Am Podiatr Med Assoc. 2014; 104(2):147-53. doi: https://doi. org/10.7547/0003-0538-104.2.147Waycaster CR, Gilligan AM, Motley TA. Cost- Effectiveness of Becaplermin Gel on Diabetic Foot Ulcer Healing. J Am Podiatr Med Assoc. 2016;106(4):273-82. doi: https://doi.org/10.7547/15- 004Zelen CM, Orgill DP, Serena T, Galiano R, Carter MJ, DiDomenico LA, et al. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safetyand cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers. Int Wound J. 2017;14(2):307-315. doi: https://doi.org/10.1111/ iwj.12600Gilligan AM, Waycaster CR, Landsman AL. Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products. J Wound Care. 2015;24(3):149-56. doi: https://doi. org/10.12968/jowc.2015.24.3.149Gilligan AM, Waycaster CR, Motley TA. Costeffectiveness of becaplermin gel on wound healing of diabetic foot ulcers. Wound Repair Regen. 2015;23(3):353-60. doi: https://doi.org/10.1111/ wrr.12285Rice JB, Desai U, Ristovska L, Cummings AK, Birnbaum HG, Skornicki M, et al. Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers. J Med Econ. 2015; 18(8):586-95. doi: https://doi.org/10.3111/13696998.2015.1031793Wilasrusmee C, Marjareonrungrung M, Eamkong S, Attia J, Poprom N, Jirasisrithum S, et al. Maggot therapy for chronic ulcer: a retrospective cohort and a meta-analysis. Asian J Surg. 2014;37(3):138-47. doi: https://doi.org/10.1016/j.asjsur.2013.09.005Aalaa M, Malazy OT, Sanjari M, Peimani M, Mohajeri-Tehrani M. Nurses’ role in diabetic foot prevention and care; a review. J Diabetes Metab Disord. 2012;11(1):24. Published 2012 Nov 21. doi: https://doi.org/10.1186/2251-6581-11-24Registered Nurses’ Association of Ontario. Valoración y manejo de las úlceras de pie diabético. En: Grispun D, Director. Guías de buenas prácticas clínicas. Canadá; 2013. p1- 162. Recuperado a partir de: https://rnao.ca/ sites/rnao-ca/files/2015_-_BPG_Foot_16_01_2015_- _2nd_Edition.pdfCOLPEDIS. Grupo Colombiano de Pie Diabético. Guías Colombianas para la prevención, diagnóstico y tratamiento del pie diabético. Tercera edición. 2019; 1- 63. Recuperado a partir de: https://es.scribd.com/ document/411231925/Guias-Colombianas-Para- La-Prevencion-Diagnostico-y-Tratamiento-Del-Pie- Diabetico-Un-Manejo-Integral-2019Parker CN, Van Netten JJ, Parker TJ, et al. Differences between national and international guidelines for the management of diabetic foot disease. Diabetes Metab Res Rev. 2019;35(2):e3101. doi: https://doi. org/10.1002/dmrr.3101Beuscher T. Guidelines for Diabetic Foot Care. A Template for the Care of All Feet. J Wound Ostomy Continence Nurs. 2019;46(3):241-245. Recuperado a partir de: https://nursing.201905000-00014.Schaper NC, van Netten JJ, Apelqvist J, et al. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36 Suppl 1:e3266. doi: https:// doi.org/10.1002/dmrr.3266Asociación latinoamericana de diabetes. Guías ALAD sobre el Diagnóstico, Control y Tratamiento de la Diabetes Mellitus Tipo 2 con Medicina Basada en Evidencia Edición 2019. 2019. Revista de la ALAD. Recuperado a partir de: http://www.revistaalad.com/ guias/5600AX191_guias_alad_2019.pdfhttp://creativecommons.org/licenses/by-nc-nd/2.5/co/Abierto (Texto Completo)Atribución-NoComercial-SinDerivadas 2.5 Colombiahttp://purl.org/coar/access_right/c_abf2Vol. 24 Núm. 1 (2021): abril - julio, 2021: Pie Diabético, Trastornos Relacionados con Sustancias, Educación Médica; 13-26Pie diabéticoManejo de atención al pacienteÚlcera del pieEficaciaAnálisis costo-beneficioMedical sciencesLife sciencesDiabetic footPatient care managementLeg ulcersEfficacyCost-benefit analysisMedical sciencesLife sciencesHealth sciencesPé diabéticoManejo do cuidado ao pacienteÚlcera do péEficáciaAnálise de custo-benefícioCiências médicasCiências da vidaCiências da saúdeCiencias médicasCiencias de la vidaCiencias de la saludCosto-efectividad de las intervenciones de enfermería para el manejo de úlceras por pie diabético: revisión sistemáticaCost-effectiveness of nursing interventions for diabetic foot ulcer management: systematic reviewCusto-efetividade das intervenções de enfermagem para o tratamento das úlceras do pé diabético: uma revisão sistemáticaArticleinfo:eu-repo/semantics/articleArtículohttp://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/coar/resource_type/c_6501http://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85Universidad Autónoma de Bucaramanga UNABFacultad Ciencias de la SaludLICENSElicense.txtlicense.txttext/plain; charset=utf-8183https://repository.unab.edu.co/bitstream/20.500.12749/25701/2/license.txt737346e09d47a3db691f1370de49426aMD52open accessTHUMBNAILArtículo.pdf.jpgArtículo.pdf.jpgIM Thumbnailimage/jpeg11674https://repository.unab.edu.co/bitstream/20.500.12749/25701/3/Art%c3%adculo.pdf.jpg8f4b2079e9cf1d15004e3f23986524f8MD53open accessORIGINALArtículo.pdfArtículo.pdfArtículoapplication/pdf652897https://repository.unab.edu.co/bitstream/20.500.12749/25701/1/Art%c3%adculo.pdf5733801e062300f2b7098ae9f4497821MD51open access20.500.12749/25701oai:repository.unab.edu.co:20.500.12749/257012024-07-24 22:02:12.189open accessRepositorio Institucional | Universidad Autónoma de Bucaramanga - UNABrepositorio@unab.edu.coTGFzIHB1YmxpY2FjaW9uZXMgZGUgbGEgcmV2aXN0YSBNZWRVTkFCIGVzdMOhbiBiYWpvIHVuYSBMaWNlbmNpYSBkZSBBdHJpYnVjacOzbiBkZSBCaWVuZXMgQ29tdW5lcyBDcmVhdGl2b3MgKENyZWF0aXZlIENvbW1vbnMsIENDKSB0aXBvIDQuMCwgY29uIGRlcmVjaG9zIGRlIGF0cmlidWNpw7NuIHkgbm8gY29tZXJjaWFs |